Table 3.
Water content |
Proton density |
|||||||
---|---|---|---|---|---|---|---|---|
Adjusted R2 | R2 change | F | p | Adjusted R2 | R2 change | F | p | |
Gray matter decreases in patients compared with control | ||||||||
PCC R | ||||||||
BPND | 0.35 | 0.06 | 3.2 | 0.082 | 0.53 | 0.06 | 3.2 | 0.082 |
T1/PD | 0.20b | 12.7b | 0.001b | 0.40b | 35.5b | <0.001b | ||
Group | 0.12b | 9.2b | 0.004b | 0.08b | 8.3b | 0.006b | ||
Group × BPND | 0.04 | 2.8 | 0.102 | 0.04 | 3.9 | 0.055 | ||
Group × T1/PD | 0.00 | 0.1 | 0.730 | 0.00 | 0.0 | 0.961 | ||
Fusiform R | ||||||||
BPND | 0.01 | 0.4 | 0.509 | 0.33 | 0.01 | 0.4 | 0.509 | |
T1/PD | 0.01 | 0.6 | 0.452 | 0.04 | 2.1 | 0.158 | ||
Group | 0.31b | 21.2b | <0.001b | 0.30 | 21.2b | <0.001b | ||
Group × BPND | 0.02 | 1.4 | 0.249 | 0.02 | 1.3 | 0.253 | ||
Group × T1/PD | 0.05 | 3.8 | 0.058 | 0.03 | 2.2 | 0.141 | ||
Insula L | ||||||||
BPND | 0.31 | 0.11b | 5.9b | 0.018b | 0.38 | 0.11b | 5.9b | 0.018b |
T1/PD | 0.15b | 9.8b | 0.003b | 0.23b | 16.6b | <0.001b | ||
Group | 0.11b | 8.1b | 0.007b | 0.08b | 6.1b | 0.017b | ||
Group × BPND | 0.01 | 0.4 | 0.515 | 0.00 | 0.3 | 0.585 | ||
Group × T1/PD | 0.00 | 0.1 | 0.820 | 0.02 | 2.0 | 0.168 | ||
Insula R | ||||||||
BPND | 0.34 | 0.06 | 3.4 | 0.072 | 0.42 | 0.06 | 3.4 | 0.072 |
T1/PD | 0.23b | 15.3b | <0.001b | 0.29b | 21.8b | <0.001b | ||
Group | 0.11b | 8.9b | 0.005b | 0.10b | 8.3b | 0.006b | ||
Group × BPND | 0.00 | 0.1 | 0.702 | 0.01 | 1.1 | 0.298 | ||
Group × T1/PD | 0.00 | 0.1 | 0.786 | 0.01 | 0.8 | 0.377 | ||
MPFC R | ||||||||
BPND | 0.68 | 0.12b | 6.6b | 0.013b | 0.77 | 0.12b | 6.6b | 0.013b |
T1/PD | 0.55b | 79.3b | <0.001b | 0.65b | 131.1b | <0.001b | ||
Group | 0.04b | 6.5b | 0.014b | 0.03b | 6.2b | 0.016b | ||
Group × BPND | 0.01 | 1.0 | 0.326 | 0.00 | 0.3 | 0.578 | ||
Group × T1/PD | 0.00 | 0.3 | 0.594 | 0.00 | 0.9 | 0.347 | ||
ACC L | ||||||||
BPND | 0.29 | 0.00 | 0.0 | 0.930 | 0.32 | 0.00 | 0.0 | 0.930 |
T1/PD | 0.13b | 6.9b | 0.012b | 0.20b | 11.8b | 0.001b | ||
Group | 0.21b | 14.6b | <0.001b | 0.16b | 11.9b | 0.001b | ||
Group × BPND | 0.02 | 1.6 | 0.206 | 0.03 | 1.9 | 0.180 | ||
Group × T1/PD | 0.00 | 0.0 | 0.861 | 0.00 | 0.2 | 0.695 | ||
Precuneus R | ||||||||
BPND | 0.62 | 0.02 | 0.8 | 0.376 | 0.59 | 0.02 | 0.8 | 0.376 |
T1/PD | 0.42b | 35.1b | <0.001b | 0.41b | 34.0b | <0.001b | ||
Group | 0.15b | 17.3b | <0.001b | 0.15b | 16.8b | <0.001b | ||
Group × BPND | 0.06b | 7.3b | 0.010b | 0.05b | 5.8b | 0.020b | ||
Group × T1/PD | 0.02 | 2.0 | 0.168 | 0.01 | 0.7 | 0.398 | ||
Precentral L | ||||||||
BPND | 0.38 | 0.00 | 0.0 | 0.925 | 0.40 | 0.00 | 0.0 | 0.925 |
T1/PD | 0.36b | 27.3b | <0.001b | 0.40b | 31.3b | <0.001b | ||
Group | 0.06b | 4.8b | 0.033b | 0.04 | 3.7 | 0.061 | ||
Group × BPND | 0.02 | 1.4 | 0.249 | 0.02 | 1.4 | 0.246 | ||
Group × T1/PD | 0.00 | 0.2 | 0.650 | 0.00 | 0.0 | 0.828 | ||
MTG L | ||||||||
BPND | 0.45 | 0.12b | 6.5b | 0.014b | 0.45 | 0.12b | 6.5b | 0.014b |
T1/PD | 0.34b | 30.0b | <0.001b | 0.35b | 31.0b | <0.001b | ||
Group | 0.03 | 2.6 | 0.116 | 0.03 | 2.8 | 0.098 | ||
Group × BPND | 0.01 | 0.5 | 0.471 | 0.01 | 0.5 | 0.505 | ||
Group × T1/PD | 0.01 | 0.9 | 0.354 | 0.01 | 0.6 | 0.431 | ||
Gray matter increases in patients compared with controls | ||||||||
Angular gyrus L | ||||||||
BPND | 0.56 | 0.32b | 22.7b | <0.001b | 0.61 | 0.32b | 22.7b | <0.001b |
T1/PD | 0.22b | 22.0b | <0.001b | 0.28b | 34.0b | <0.001b | ||
Group | 0.06b | 6.4b | 0.015b | 0.04b | 4.6b | 0.038b | ||
Group × BPND | 0.00 | 0.0 | 0.899 | 0.01 | 0.6 | 0.439 | ||
Group × T1/PD | 0.01 | 1.5 | 0.225 | 0.01 | 0.6 | 0.430 | ||
Cuneus R | ||||||||
BPND | 0.81 | 0.70b | 114.0b | <0.001b | 0.87 | 0.70b | 114.0b | <0.001b |
T1/PD | 0.12b | 33.7b | <0.001b | 0.17b | 65.6b | <0.001b | ||
Group | 0.00 | 1.0 | 0.324 | 0.00 | 1.1 | 0.298 | ||
Group × BPND | 0.00 | 0.9 | 0.358 | 0.01 | 2.0 | 0.160 | ||
Group × T1/PD | 0.00 | 0.1 | 0.794 | 0.00 | 0.1 | 0.795 | ||
Postcentral gyrus R | ||||||||
BPND | 0.40 | 0.22b | 13.6b | 0.001b | 0.47 | 0.22b | 13.6b | 0.001b |
T1/PD | 0.18b | 14.6b | <0.001b | 0.24b | 20.7b | <0.001b | ||
Group | 0.05b | 4.5b | 0.039b | 0.04 | 3.7 | 0.059 | ||
Group × BPND | 0.01 | 0.5 | 0.491 | 0.01 | 0.6 | 0.447 | ||
Group × T1/PD | 0.01 | 0.4 | 0.531 | 0.03 | 2.4 | 0.130 |
aGMV served as the dependent variable; flumazenil BPND, T1 time (water content) or proton density (PD), group (patients or controls), and the interaction terms served as the explanatory variables in the multiple regression analysis. L, Left; R, right.
bSignificant with cluster-level correction across the whole brain at p < 0.05.